Marie Claire O’dWyer

Marie Claire O’dWyer

Auto-generated profile, based on publicly available information

Marie Claire O’dWyer

Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2025 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
Diane M. HarperDiane M. Harper
Diane M. Harper
AYAlisa P. Young
Alisa P. Young
MOMarie Claire O’dWyer
Marie Claire O’dWyer
MOMutiya Olorunfemi
Mutiya Olorunfemi
ALAnna Laurie
Anna Laurie
HWHeather Walline
Heather Walline
Background: Human papillomavirus (HPV) assays and self-collection devices for HPV detection have evolved. We aim to compare two self-sampling devices against speculum-based testing for HPV genotype agreement and their accuracy for cervical intraepithelial neoplasia grade 2 (CIN2+) disease. Secondarily, we aim to compare two HPV assays for different HPV genotype detection agreement and their accuracy for CIN2+ disease. Methods: Women from colposcopy (N = 97) and primary care (N = 96) were block-randomized to two different self-sampling device groups. Self-sampling and speculum-collected pairs of HPV specimens were analyzed with the research assay. A second speculum-collected specimen provided clinical results using the clinical HPV assay. Agreement (prevalence-based κ) and accuracy (sensitivity/specificity ratios) provided the statistical comparison. Results: The two devices did not differ in their κ agreement scores for overall HPV detection compared with the speculum-collected sample [κ = 0.83 (0.72–0.94) and κ = 0.90 (0.81–0.98), respectively, nonsignificant exact McNemar test results]. The two devices did not differ in accuracy as measured by the relative sensitivity/specificity for overall HPV at the CIN2+ disease threshold [1.0 (0.15–6.77) and 1.19 (0.56–2.54), respectively]. The two assays did not differ in HPV agreement nor assay accuracy for CIN2+ (n = 10). Conclusions: HPV self-sampling devices robustly detected high-risk HPV types for cervical cancer screening when using the research assay to compare them. Both research and clinical HPV assays provide equivalent HPV detection for specific and aggregated HPV types. Impact: This study provides a US-based population to show that self-collection for primary HPV testing is accurate for CIN2+ detection with multiple devices using a validated HPV assay.

24 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
Diane M. HarperDiane M. Harper
Diane M. Harper
CSCourtney Streur
Courtney Streur
MRMonica W. Rosen
Monica W. Rosen
PLPaul Lin
Paul Lin
LCLaura Crespo-Albiac
Laura Crespo-Albiac
NKNeil Kamdar
Neil Kamdar
Background: Women with physical disabilities (WPD) can develop cervical cancer and die. Cervical cancer screening (CCS) rates are lower for WPD than those without disabilities. We aim to explore the sociodemographic factors associated with colposcopy utilization among WPD and women with no physical disabilities. Methods: The Truveta dataset is generalizable to the U.S. and contains medical codes for colposcopy and CCS events, and definitions of physical disabilities. Race and ethnicity were self-assigned. The social determinant of health, some college education, was linked to the dataset. Age was determined at the time of CCS. Women aged 21-65 years, without a hysterectomy or prior cancer, were included in the January 1, 2017-December 31, 2022 time frame. Multivariable logistic regression allowed predictions of colposcopy by disability status based on age, race, ethnicity, and education. Findings: WPD aged 50-65 years had significantly greater colposcopy rates than women with no physical disabilities (2.8% vs. 1.9%, p=0.003). Among WPD, those aged 50-65 years had significantly lower odds of colposcopy than those aged 30-39 (aOR=0.57 (95% CI: 0.36-0.91) and had increased odds if attending some college vs. no college (aOR=1.44 (1.04-1.99, p=0.021). When compared to those with no physical disabilities, WPD had 18% increased odds of colposcopy (aOR=1.18 (1.06-1.31, p=0.003), seen among White women (aOR=1.65 (1.18-2.31, p<0.001) and those with some college (aOR=1.32 (1.10- 1.59, p<0.001). Interpretation: In this cross-sectional study, we found that, among sociodemographic descriptors, disability, age, and education were associated with colposcopy.

1 July 2025
Verified
Other
Open access
Diane M. HarperDiane M. Harper
Diane M. Harper
AYAlisa P. Young
Alisa P. Young
MOMarie Claire O’dWyer
Marie Claire O’dWyer
MOMutiya Olorunfemi
Mutiya Olorunfemi
ALAnna Laurie
Anna Laurie
HWHeather Walline
Heather Walline
Supplemental Table 4. Accuracy of HPV assays: comparing the research assay to the clinical assay from speculum-based specimens. HPV means human papillomavirus TP means true positive: assay detected HPV in the presence of CIN2+ disease. FP means false positive: assay detected HPV in non-diseased cohort

1 July 2025
Verified
Other
Open access
Diane M. HarperDiane M. Harper
Diane M. Harper
AYAlisa P. Young
Alisa P. Young
MOMarie Claire O’dWyer
Marie Claire O’dWyer
MOMutiya Olorunfemi
Mutiya Olorunfemi
ALAnna Laurie
Anna Laurie
HWHeather Walline
Heather Walline
Supplementary Figure 1. Trial design

29 September 2026 in Menopause
Verified
Journal Article
Closed access
MOMarie Claire O’DWyer
Marie Claire O’DWyer
LMLeigh Morrison
Leigh Morrison
SKShubham Kalwani
Shubham Kalwani
CMChidera Mgbudem
Chidera Mgbudem
NPNaomi Pang
Naomi Pang
Diane M. HarperDiane M. Harper
Diane M. Harper
Objectives: Family physicians care for women across the lifespan, yet little is known about the menopause education they receive during training. We conducted a national survey of US family medicine program directors to characterize the current state of menopause education, including curriculum structure, didactic content, clinical training, and program directors’ perspectives on improvement and standardization. Methods: A cross-sectional survey on menopause education was embedded within the Council of Academic Family Medicine Educational Research Alliance (CERA) omnibus survey, which is administered biannually to family medicine residency program directors and collects standardized program demographic data. Results: Of 313 family medicine program directors who responded to the omnibus survey (44.7% response rate), 279 completed the menopause-specific questions. The majority (94%) reported either a dedicated menopause curriculum or menopause education integrated within a broader women’s health curriculum. Overall 56% of program directors agreed there was a need to improve menopause education; those with an established formal curriculum were less likely to agree (46% vs. 61%, P =0.02), although interest in a standardized national curriculum was similarly high across groups. Conclusions: Menopause education is broadly incorporated across US family medicine residency training, reflecting a meaningful foundation for evidence-based menopause care. However, didactic volume remains limited, content coverage is variable, and training relies heavily on continuity clinic exposure, with little formal assessment. Scalable, on-demand learning modules with competency assessment represent a promising avenue for strengthening menopause training.

1 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CSCourtney Streur
Courtney Streur
PLPaul Lin
Paul Lin
NKNeil Kamdar
Neil Kamdar
AYAlisa P. Young
Alisa P. Young
AVAlexandra Vinson
Alexandra Vinson
Diane M. HarperDiane M. Harper
Diane M. Harper
Background: Women with physical disabilities die from cervical cancer, with known lower cancer screening rates than the general population. Indeed, women with congenital physical disabilities have less cervical cancer screening (CCS) than women with acquired physical disabilities. Yet, congenital disabilities are etiologically distinct, requiring different emphases from healthcare. We aim to evaluate the CCS among women with two forms of congenital physical disabilities: cerebral palsy (CP) or spina bifida (SB).Methods: We designed a population-based cross-sectional study from Jan 1, 2017, through Dec 31, 2022, with CCS as the measured outcome. We recognized that women with SB have complications with pelvic organ prolapse (POP); therefore, we used multiplicative intersecting modeling of CCS by disability status to evaluate the intracategorical effects of age, race, ethnicity, college, and POP, with Firth corrections and Tukey post hoc testing for multiple comparisons.Findings: Women with CP (n=3828) were demographically significantly younger and more often of Black race, but had a lower prolapse rate compared to women with SB (n=2046). Women with CP had a lower CCS rate than women with SB (51·4% vs 69·9%, p<0·001). Women with CP had significantly lower adjusted odds of CCS than women with SB for all covariates except women aged 50-65, of Black race, and with POP.Interpretation: Women with SB have associations with CCS that are similar to the general reference population of women without physical disabilities. In contrast, women with CP have distinct deficits in CCS that require different targeted interventions to improve cancer prevention.